drugset / Trial / NCT05367635
A Study of SKB315 in Patients With Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB315 for injection in patients with advanced solid tumors.
Timeline
- Start
- 2022-03-16
- Primary completion
- 2026-06-30
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SKB315 | Unknown | — | — |
| Background | Capecitabine | Small molecule | — | — |
| Background | KL-A167 | Unknown | — | — |